Please use this identifier to cite or link to this item:
|Title:||Synthesis and QSAR studies of 16-(3-methoxy-4-substituted benzylidene) androstene derivatives as anticancer agents|
Jindal, Dharam Paul
Satyanarayan, Yalamanchili Darji
in vitro activity
|Abstract:||<smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="City"><smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="place"><smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region"> In a systematic effort aimed at identifying new steroidal cytotoxic agents with potent antipoliferative activity against cancer cells and developing their QSAR models, a series of 16-(3-methoxy-4-substituted benzylidene)androst-5-ene derivatives have been synthesized. The selected compounds are evaluated for antineoplastic activity against a panel of three human cell lines-breast, CNS and lungs at NCI, Bethesda, USA. The results presented herein indicate that compound <b style="">15-18, 21, 22, 25-30 </b>are active anticancer agents. The QSAR investigation with multiple linear regression analysis has been applied to find a correlation between different calculated physicochemical parameters of these compounds and biological activity. Application of datasets by using CODESSA software has led to QSAR equations based on the 3 descriptors. The significant QSAR models have been obtained with R<sup>2</sup> values which range from 0.9692-0.8225 and good predictive performance (q<sup>2</sup> range: 0.9264-0.7121). These models are expected to be useful for the anticancer screening of androstene derivatives having substitution at position 3,16 and 17 of steroid nucleus. </smarttagtype></smarttagtype></smarttagtype>|
|Appears in Collections:||IJC-B Vol.49B(07) [July 2010]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.